| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 39 | 2023 | 127 | 11.780 |
Why?
|
| Cytochrome P-450 CYP1A1 | 41 | 2023 | 82 | 7.640 |
Why?
|
| Lung Injury | 18 | 2023 | 118 | 6.010 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 16 | 2025 | 67 | 5.750 |
Why?
|
| Cytochrome P-450 CYP1A2 | 21 | 2023 | 48 | 5.260 |
Why?
|
| Receptors, Aryl Hydrocarbon | 23 | 2023 | 63 | 4.560 |
Why?
|
| Acute Lung Injury | 11 | 2022 | 62 | 4.470 |
Why?
|
| Bronchopulmonary Dysplasia | 15 | 2023 | 184 | 4.260 |
Why?
|
| Lung | 33 | 2023 | 1468 | 3.890 |
Why?
|
| DNA Adducts | 27 | 2025 | 78 | 3.660 |
Why?
|
| Methylcholanthrene | 13 | 2010 | 19 | 2.850 |
Why?
|
| Liver | 31 | 2023 | 1727 | 2.780 |
Why?
|
| Cytochrome P-450 Enzyme System | 14 | 2023 | 135 | 2.630 |
Why?
|
| Carcinogens | 11 | 2015 | 153 | 2.460 |
Why?
|
| Oxidative Stress | 13 | 2021 | 796 | 2.220 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 7 | 2022 | 377 | 1.960 |
Why?
|
| Oxygen | 10 | 2023 | 540 | 1.590 |
Why?
|
| Cytochrome P-450 CYP1B1 | 9 | 2018 | 30 | 1.460 |
Why?
|
| Mice, Inbred C57BL | 30 | 2023 | 4342 | 1.410 |
Why?
|
| Animals | 89 | 2024 | 33693 | 1.400 |
Why?
|
| Omeprazole | 5 | 2016 | 98 | 1.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2023 | 226 | 1.170 |
Why?
|
| beta-Naphthoflavone | 6 | 2020 | 10 | 1.140 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 5 | 2021 | 26 | 1.130 |
Why?
|
| Gene Expression Regulation | 16 | 2022 | 2533 | 1.130 |
Why?
|
| Mice | 54 | 2024 | 17469 | 1.100 |
Why?
|
| Mice, Knockout | 20 | 2023 | 3710 | 1.030 |
Why?
|
| Transcriptional Activation | 4 | 2011 | 481 | 0.990 |
Why?
|
| Enzyme Induction | 17 | 2018 | 103 | 0.980 |
Why?
|
| Transcriptome | 5 | 2019 | 908 | 0.950 |
Why?
|
| Carcinogenesis | 3 | 2024 | 328 | 0.950 |
Why?
|
| Cytochrome P-450 CYP3A | 6 | 2019 | 59 | 0.950 |
Why?
|
| Gene Expression Regulation, Enzymologic | 8 | 2016 | 256 | 0.930 |
Why?
|
| DNA Damage | 4 | 2018 | 506 | 0.930 |
Why?
|
| Pulmonary Alveoli | 7 | 2019 | 132 | 0.920 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2024 | 69 | 0.860 |
Why?
|
| Microsomes, Liver | 11 | 2012 | 86 | 0.860 |
Why?
|
| DNA | 15 | 2007 | 1592 | 0.850 |
Why?
|
| Benzo(a)pyrene | 9 | 2014 | 19 | 0.830 |
Why?
|
| Animals, Newborn | 14 | 2023 | 988 | 0.790 |
Why?
|
| Gene Expression Profiling | 6 | 2019 | 1684 | 0.790 |
Why?
|
| Neutrophil Infiltration | 7 | 2016 | 65 | 0.780 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 7 | 2012 | 43 | 0.730 |
Why?
|
| Promoter Regions, Genetic | 7 | 2018 | 1335 | 0.730 |
Why?
|
| Enzyme Inhibitors | 6 | 2017 | 571 | 0.730 |
Why?
|
| Docosahexaenoic Acids | 2 | 2024 | 66 | 0.710 |
Why?
|
| Placenta | 2 | 2025 | 493 | 0.670 |
Why?
|
| Sex Characteristics | 4 | 2021 | 312 | 0.660 |
Why?
|
| Environmental Pollution | 1 | 2019 | 11 | 0.660 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1581 | 0.630 |
Why?
|
| Paclitaxel | 2 | 2017 | 122 | 0.630 |
Why?
|
| Tretinoin | 2 | 2010 | 116 | 0.600 |
Why?
|
| Blotting, Western | 9 | 2017 | 1102 | 0.560 |
Why?
|
| Rats | 23 | 2017 | 3629 | 0.550 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 670 | 0.520 |
Why?
|
| Rifampin | 2 | 2018 | 145 | 0.520 |
Why?
|
| Proton Pump Inhibitors | 2 | 2015 | 253 | 0.520 |
Why?
|
| Chromatography, Thin Layer | 2 | 2015 | 41 | 0.510 |
Why?
|
| Deoxyadenosines | 1 | 2015 | 9 | 0.500 |
Why?
|
| Protective Agents | 1 | 2015 | 31 | 0.500 |
Why?
|
| Proteome | 1 | 2017 | 233 | 0.500 |
Why?
|
| Infant, Newborn | 11 | 2023 | 8070 | 0.500 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 80 | 0.490 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 595 | 0.490 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 90 | 0.480 |
Why?
|
| Premature Birth | 1 | 2019 | 380 | 0.480 |
Why?
|
| Humans | 48 | 2025 | 122998 | 0.480 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 4263 | 0.470 |
Why?
|
| Female | 48 | 2025 | 65310 | 0.450 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2008 | 1211 | 0.420 |
Why?
|
| Interleukin-6 | 1 | 2015 | 393 | 0.420 |
Why?
|
| Infant, Premature | 4 | 2022 | 798 | 0.420 |
Why?
|
| RNA, Messenger | 12 | 2015 | 2820 | 0.420 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2020 | 102 | 0.410 |
Why?
|
| Pentachlorophenol | 4 | 1996 | 4 | 0.410 |
Why?
|
| Pneumonia | 1 | 2016 | 325 | 0.410 |
Why?
|
| Male | 38 | 2023 | 59901 | 0.400 |
Why?
|
| Metabolic Detoxication, Phase II | 2 | 2011 | 14 | 0.400 |
Why?
|
| Lipid Peroxidation | 4 | 2018 | 82 | 0.400 |
Why?
|
| Organ Size | 5 | 2015 | 412 | 0.390 |
Why?
|
| Carcinogens, Environmental | 3 | 2010 | 16 | 0.390 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 34 | 0.390 |
Why?
|
| DNA Repair | 5 | 2017 | 582 | 0.380 |
Why?
|
| Fish Oils | 1 | 2011 | 82 | 0.370 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2003 | 239 | 0.370 |
Why?
|
| Tamoxifen | 4 | 1997 | 363 | 0.370 |
Why?
|
| Pregnancy | 10 | 2025 | 7115 | 0.360 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1675 | 0.360 |
Why?
|
| Luciferases | 4 | 2016 | 137 | 0.350 |
Why?
|
| Anticarcinogenic Agents | 1 | 2010 | 55 | 0.350 |
Why?
|
| Genes, Reporter | 5 | 2016 | 381 | 0.350 |
Why?
|
| Benzopyrenes | 2 | 2003 | 4 | 0.350 |
Why?
|
| Transfection | 4 | 2016 | 1068 | 0.350 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2306 | 0.330 |
Why?
|
| Glutathione Transferase | 3 | 2008 | 153 | 0.330 |
Why?
|
| Endothelial Cells | 4 | 2015 | 528 | 0.310 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 1013 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1874 | 0.300 |
Why?
|
| Signal Transduction | 9 | 2020 | 4507 | 0.290 |
Why?
|
| RNA, Small Interfering | 6 | 2018 | 663 | 0.290 |
Why?
|
| Glucuronosyltransferase | 4 | 2017 | 69 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2015 | 1684 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1294 | 0.280 |
Why?
|
| Cells, Cultured | 9 | 2017 | 3050 | 0.270 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2021 | 92 | 0.270 |
Why?
|
| Isoxazoles | 2 | 2017 | 31 | 0.270 |
Why?
|
| Body Weight | 4 | 2015 | 999 | 0.270 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 1684 | 0.260 |
Why?
|
| Lipopolysaccharides | 4 | 2016 | 291 | 0.260 |
Why?
|
| Hep G2 Cells | 3 | 2018 | 88 | 0.260 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 143 | 0.250 |
Why?
|
| Random Allocation | 3 | 2015 | 423 | 0.240 |
Why?
|
| Sulfotransferases | 2 | 1995 | 27 | 0.240 |
Why?
|
| Sex Factors | 4 | 2023 | 1254 | 0.240 |
Why?
|
| Blood Vessels | 1 | 2005 | 104 | 0.230 |
Why?
|
| Dinoprost | 2 | 2015 | 28 | 0.230 |
Why?
|
| Growth Differentiation Factor 15 | 3 | 2023 | 16 | 0.230 |
Why?
|
| Injections, Intraperitoneal | 3 | 2015 | 72 | 0.230 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 2 | 2002 | 4 | 0.230 |
Why?
|
| Bentonite | 1 | 2023 | 1 | 0.220 |
Why?
|
| Ligands | 2 | 2023 | 533 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 515 | 0.220 |
Why?
|
| Computational Biology | 3 | 2019 | 799 | 0.220 |
Why?
|
| Biotransformation | 6 | 2012 | 49 | 0.220 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2024 | 78 | 0.220 |
Why?
|
| Phosphorus Radioisotopes | 6 | 2015 | 17 | 0.210 |
Why?
|
| Nitric Oxide | 1 | 2006 | 432 | 0.210 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2018 | 92 | 0.200 |
Why?
|
| Epoxide Hydrolases | 2 | 2008 | 33 | 0.200 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 48 | 0.200 |
Why?
|
| Machine Learning | 1 | 2025 | 213 | 0.200 |
Why?
|
| Cell Survival | 5 | 2015 | 803 | 0.200 |
Why?
|
| Gene Expression | 1 | 2007 | 1569 | 0.200 |
Why?
|
| Epithelial Cells | 4 | 2016 | 900 | 0.200 |
Why?
|
| Inflammation | 7 | 2022 | 1400 | 0.190 |
Why?
|
| Gonadal Hormones | 1 | 2021 | 3 | 0.190 |
Why?
|
| Sex Chromosomes | 1 | 2021 | 34 | 0.190 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2014 | 60 | 0.180 |
Why?
|
| Mice, Inbred ICR | 8 | 1997 | 147 | 0.180 |
Why?
|
| Colitis | 1 | 2022 | 152 | 0.180 |
Why?
|
| Kidney | 5 | 1997 | 1337 | 0.180 |
Why?
|
| Polycyclic Compounds | 2 | 2005 | 4 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2024 | 619 | 0.180 |
Why?
|
| Membrane Proteins | 3 | 2019 | 1524 | 0.170 |
Why?
|
| Time Factors | 5 | 2016 | 6198 | 0.170 |
Why?
|
| Ampicillin | 1 | 2019 | 58 | 0.170 |
Why?
|
| Cytokines | 5 | 2017 | 1280 | 0.170 |
Why?
|
| Rats, Inbred F344 | 4 | 2014 | 102 | 0.170 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2020 | 105 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 352 | 0.160 |
Why?
|
| Petroleum | 1 | 2019 | 1 | 0.160 |
Why?
|
| Pregnenolone Carbonitrile | 3 | 1997 | 3 | 0.160 |
Why?
|
| Soil Pollutants | 1 | 2019 | 9 | 0.160 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2017 | 29 | 0.160 |
Why?
|
| Triazoles | 1 | 2000 | 138 | 0.160 |
Why?
|
| Lipid Peroxides | 1 | 2018 | 15 | 0.160 |
Why?
|
| Autoradiography | 3 | 2015 | 71 | 0.160 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 382 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 2391 | 0.160 |
Why?
|
| Aorta | 1 | 2002 | 540 | 0.150 |
Why?
|
| Oxidoreductases | 2 | 1995 | 92 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 313 | 0.150 |
Why?
|
| Mitochondria | 1 | 2023 | 682 | 0.150 |
Why?
|
| Biomarkers | 4 | 2017 | 2940 | 0.150 |
Why?
|
| Hepatocytes | 2 | 2017 | 225 | 0.140 |
Why?
|
| Microsomes | 3 | 2011 | 55 | 0.140 |
Why?
|
| RNA Interference | 2 | 2016 | 496 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2005 | 828 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 3283 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2017 | 867 | 0.140 |
Why?
|
| Bufanolides | 1 | 2017 | 18 | 0.140 |
Why?
|
| Enzymes | 1 | 2017 | 51 | 0.140 |
Why?
|
| Fetus | 3 | 2015 | 570 | 0.140 |
Why?
|
| Metabolome | 1 | 2019 | 294 | 0.140 |
Why?
|
| Camptothecin | 1 | 2017 | 76 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 34 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 335 | 0.140 |
Why?
|
| Estrogen Antagonists | 1 | 1997 | 103 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2023 | 831 | 0.130 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 144 | 0.130 |
Why?
|
| Reactive Oxygen Species | 5 | 2023 | 481 | 0.130 |
Why?
|
| Receptors, Steroid | 1 | 2018 | 269 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 102 | 0.130 |
Why?
|
| Microvessels | 1 | 2016 | 56 | 0.130 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 113 | 0.130 |
Why?
|
| Benzoflavones | 1 | 1995 | 1 | 0.130 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2012 | 28 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 211 | 0.130 |
Why?
|
| Teichoic Acids | 2 | 2012 | 13 | 0.130 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2015 | 18 | 0.130 |
Why?
|
| Pulmonary Edema | 2 | 2017 | 49 | 0.130 |
Why?
|
| Diethylstilbestrol | 1 | 1995 | 142 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3090 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 45 | 0.130 |
Why?
|
| Activation, Metabolic | 1 | 2015 | 5 | 0.130 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 3 | 2012 | 56 | 0.130 |
Why?
|
| Immunologic Factors | 1 | 2017 | 179 | 0.130 |
Why?
|
| Transcription Factor RelB | 1 | 2015 | 6 | 0.120 |
Why?
|
| Adult | 5 | 2025 | 28980 | 0.120 |
Why?
|
| Limit of Detection | 1 | 2015 | 59 | 0.120 |
Why?
|
| Biological Products | 1 | 2017 | 113 | 0.120 |
Why?
|
| Malondialdehyde | 1 | 2015 | 35 | 0.120 |
Why?
|
| Aldehydes | 1 | 2015 | 28 | 0.120 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 23 | 0.120 |
Why?
|
| Capillaries | 1 | 2015 | 66 | 0.120 |
Why?
|
| DNA, Complementary | 1 | 2016 | 463 | 0.120 |
Why?
|
| Anti-Ulcer Agents | 1 | 2015 | 111 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2014 | 611 | 0.120 |
Why?
|
| Mice, Inbred Strains | 2 | 2014 | 310 | 0.120 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2014 | 6 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2015 | 247 | 0.120 |
Why?
|
| Adrenomedullin | 1 | 2015 | 74 | 0.120 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 1695 | 0.120 |
Why?
|
| Pulmonary Circulation | 1 | 2015 | 121 | 0.120 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 114 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2016 | 459 | 0.110 |
Why?
|
| Caffeine | 1 | 2014 | 71 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 1994 | 68 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2016 | 471 | 0.110 |
Why?
|
| Proteomics | 1 | 2017 | 480 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 353 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 414 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 123 | 0.110 |
Why?
|
| Benzene Derivatives | 2 | 2007 | 19 | 0.110 |
Why?
|
| Pyrenes | 2 | 2023 | 5 | 0.110 |
Why?
|
| Chlorpromazine | 1 | 2012 | 12 | 0.110 |
Why?
|
| Pharmacokinetics | 1 | 2012 | 16 | 0.110 |
Why?
|
| Apoptosis | 3 | 2015 | 1783 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 313 | 0.100 |
Why?
|
| Neutrophils | 1 | 2015 | 372 | 0.100 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 84 | 0.100 |
Why?
|
| Antioxidants | 1 | 2015 | 337 | 0.100 |
Why?
|
| Midazolam | 1 | 2012 | 49 | 0.100 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 47 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2015 | 223 | 0.100 |
Why?
|
| Drug Synergism | 3 | 2014 | 240 | 0.100 |
Why?
|
| Alleles | 1 | 2017 | 1602 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 678 | 0.100 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2011 | 10 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 80 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2015 | 471 | 0.100 |
Why?
|
| Cell Line | 3 | 2015 | 2779 | 0.090 |
Why?
|
| Soil | 2 | 2023 | 48 | 0.090 |
Why?
|
| Drug Interactions | 3 | 2017 | 252 | 0.090 |
Why?
|
| Genotype | 1 | 2017 | 2546 | 0.090 |
Why?
|
| Texas | 1 | 2019 | 3542 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 996 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 1586 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2019 | 619 | 0.080 |
Why?
|
| Inactivation, Metabolic | 3 | 2018 | 32 | 0.080 |
Why?
|
| Models, Biological | 2 | 2007 | 1442 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2011 | 340 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 279 | 0.080 |
Why?
|
| Apoproteins | 1 | 2008 | 20 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 49 | 0.080 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 482 | 0.080 |
Why?
|
| Risk Factors | 2 | 2021 | 9974 | 0.080 |
Why?
|
| Spices | 1 | 2007 | 3 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2395 | 0.070 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2008 | 39 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2848 | 0.070 |
Why?
|
| Cytochromes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 810 | 0.070 |
Why?
|
| Isotope Labeling | 3 | 2003 | 102 | 0.070 |
Why?
|
| Cytochrome P-450 CYP1A2 Inhibitors | 1 | 2006 | 3 | 0.070 |
Why?
|
| Quinone Reductases | 1 | 2006 | 3 | 0.070 |
Why?
|
| NADPH Dehydrogenase | 1 | 2006 | 7 | 0.070 |
Why?
|
| Lymphoid Tissue | 1 | 2006 | 44 | 0.070 |
Why?
|
| Acute-Phase Proteins | 1 | 2005 | 46 | 0.060 |
Why?
|
| Diet | 2 | 2011 | 1125 | 0.060 |
Why?
|
| Sulfates | 2 | 1995 | 34 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2007 | 346 | 0.060 |
Why?
|
| Oxazines | 2 | 2007 | 25 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 666 | 0.060 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2025 | 24 | 0.060 |
Why?
|
| Phenobarbital | 2 | 1997 | 36 | 0.060 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2004 | 5 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 258 | 0.050 |
Why?
|
| Phosphorus Isotopes | 1 | 2003 | 8 | 0.050 |
Why?
|
| Tight Junction Proteins | 1 | 2022 | 12 | 0.050 |
Why?
|
| Temperature | 1 | 2023 | 306 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2022 | 46 | 0.050 |
Why?
|
| Coumarins | 1 | 2022 | 23 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2022 | 27 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 465 | 0.050 |
Why?
|
| Benzopyrene Hydroxylase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2002 | 44 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 214 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 927 | 0.050 |
Why?
|
| Protective Factors | 1 | 2021 | 84 | 0.050 |
Why?
|
| Survival Rate | 1 | 2006 | 1993 | 0.050 |
Why?
|
| Homozygote | 1 | 2003 | 533 | 0.050 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 2 | 1998 | 8 | 0.050 |
Why?
|
| Plasmids | 1 | 2002 | 511 | 0.040 |
Why?
|
| Breast | 1 | 2002 | 214 | 0.040 |
Why?
|
| Response Elements | 1 | 2000 | 97 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 1300 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 455 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 162 | 0.040 |
Why?
|
| Hydrocarbons | 1 | 2019 | 8 | 0.040 |
Why?
|
| Biodegradation, Environmental | 1 | 2019 | 12 | 0.040 |
Why?
|
| Testis | 1 | 2021 | 405 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 2000 | 100 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 681 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 409 | 0.040 |
Why?
|
| Gestational Age | 1 | 2022 | 1116 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2019 | 120 | 0.040 |
Why?
|
| Ovary | 1 | 2021 | 389 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1998 | 70 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 372 | 0.040 |
Why?
|
| Mutagens | 1 | 1998 | 84 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 98 | 0.040 |
Why?
|
| Carboxylesterase | 1 | 2017 | 10 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2017 | 118 | 0.040 |
Why?
|
| Butadienes | 1 | 1996 | 19 | 0.030 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 18 | 0.030 |
Why?
|
| 7-Alkoxycoumarin O-Dealkylase | 2 | 1993 | 2 | 0.030 |
Why?
|
| Corn Oil | 1 | 1995 | 11 | 0.030 |
Why?
|
| Acetaminophen | 1 | 1997 | 91 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 2012 | 151 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme Inducers | 1 | 2015 | 2 | 0.030 |
Why?
|
| Hydroxylation | 1 | 1995 | 45 | 0.030 |
Why?
|
| Poly I-C | 1 | 2015 | 22 | 0.030 |
Why?
|
| Brain | 1 | 2007 | 2943 | 0.030 |
Why?
|
| Thymidine | 2 | 1992 | 53 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1267 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 224 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 101 | 0.030 |
Why?
|
| Diquat | 1 | 1995 | 1 | 0.030 |
Why?
|
| Waste Products | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 242 | 0.030 |
Why?
|
| Necrosis | 1 | 2015 | 205 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 697 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 350 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1996 | 253 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 515 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 793 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2014 | 285 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 568 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2012 | 98 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 491 | 0.030 |
Why?
|
| Neoplasms | 2 | 2020 | 2750 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2012 | 312 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2012 | 87 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 141 | 0.030 |
Why?
|
| Reference Values | 1 | 1993 | 696 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2011 | 39 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 519 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 177 | 0.020 |
Why?
|
| Epithelium | 1 | 2012 | 366 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 176 | 0.020 |
Why?
|
| Kinetics | 1 | 1993 | 1313 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 714 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 528 | 0.020 |
Why?
|
| DNA Replication | 1 | 1992 | 343 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2012 | 163 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3259 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2012 | 261 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2019 | 2577 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2012 | 387 | 0.020 |
Why?
|
| Neoplasms, Experimental | 2 | 2002 | 211 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2006 | 258 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 13 | 0.020 |
Why?
|
| Myeloproliferative Disorders | 1 | 2006 | 90 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 849 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 374 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 473 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 804 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 607 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12087 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 2227 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 1845 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1063 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2698 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 3871 | 0.010 |
Why?
|
| Milk, Human | 1 | 2002 | 296 | 0.010 |
Why?
|
| Chrysenes | 1 | 1998 | 1 | 0.010 |
Why?
|
| Mutagenicity Tests | 1 | 1998 | 36 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 462 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 559 | 0.010 |
Why?
|
| Skin | 1 | 1998 | 505 | 0.010 |
Why?
|
| Hydroquinones | 1 | 1994 | 10 | 0.010 |
Why?
|
| Binding Sites | 1 | 1997 | 1292 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 5773 | 0.010 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1992 | 10 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1993 | 83 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 1015 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1993 | 303 | 0.010 |
Why?
|
| Aged | 1 | 2007 | 19035 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 19030 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 25931 | 0.000 |
Why?
|
| Child | 1 | 2007 | 24144 | 0.000 |
Why?
|
| Aging | 1 | 1993 | 1173 | 0.000 |
Why?
|